NEERAJ SHARMA, MD
Medical Oncology Physician · LONGVIEW, TX
Individual Active NPI 1851334759
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 907 | 153,540 | $10,649,865 | $2,667,684 | $2,127,408 |
| 2023 | 856 | 188,131 | $13,114,003 | $3,500,293 | $2,787,519 |
| 2022 | 911 | 183,713 | $12,669,383 | $3,638,959 | $2,903,891 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 15,300 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,234 | $0 | $0 |
| J9025 | Injection, azacitidine, 1 mg | 13,405 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11,825 | $3 | $2 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,900 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 8,158 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 7,700 | $52 | $41 |
| J1453 | Injection, fosaprepitant, 1 mg | 7,200 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 3,600 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,855 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,747 | $0 | $0 |
| 36415 | Insertion of needle into vein for collection of blood sample | 1,714 | $9 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | L1459 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1942242995
- NPI 1821031253
- NPI 1295050037
- NPI 1629269774
- NPI 1346331063
- NPI 1497319636
- NPI 1346323888
- NPI 1447414776
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.